|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Net sales | |||||
| Cost of sales | |||||
| Gross profit | |||||
| Royalty overrides | |||||
| Selling, general, and administrative expenses | |||||
| Selling expenses | |||||
| General and administrative expenses | |||||
| Other operating income | |||||
| Operating income | |||||
| Interest expense | |||||
| Interest income | |||||
| Other expense (income), net | |||||
| Income before income taxes | |||||
| Income taxes | |||||
| Net Income | |||||
| Net loss attributable to noncontrolling interest | |||||
| Net income attributable to Herbalife | |||||
| Earnings per share attributable to Herbalife: | |||||
| Basic | |||||
| Diluted | |||||
| Weighted-average shares outstanding: | |||||
| Basic | |||||
| Diluted |
Loading...
